PS Ratio: 5.45

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 5.45 is 70% below its estimated 1-year average of 18.12, near the low end of its estimated 1-year range (5.23–275.46).

As of 2026-10-06T14:52:52.668Z. 69.92% below its estimated 12-month average of 18.12.

LENZ PS Ratio Metrics

P/S vs. estimated history

At 5.45, P/S is below its estimated 1-year median — higher than 1% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for LENZ Therapeutics, Inc. (LENZ)?

The P/S ratio for LENZ stock is 5.45.

Is LENZ Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 5.45 is 70% below its estimated 1-year average of 18.12, near the low end of its estimated 1-year range (5.23–275.46).

What is the estimated TTM average P/S ratio for LENZ Therapeutics, Inc. (LENZ)?

The estimated TTM average P/S ratio for LENZ stock is 18.12.

Showing the most recent 260 of 297 data points. The chart above shows the full history.

Related Metrics